Panelists discuss how real-world outcomes inform patient conversations and support shared decision-making for third-line ...
Panelists explain that in the absence of head-to-head trial data, real-world evidence (RWE) becomes crucial in guiding ...
Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative ...
Amid a government shutdown in nearby Washington, DC, Paul Ryan, former speaker of the House, told attendees at the Academy of ...
CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating ...
Olfactory dysfunction in MS may be linked to nasal microbial changes, not just central inflammation. MS patients showed lower ...
A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...
MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often ...
AI is revolutionizing healthcare by improving diagnostics, reducing clinician workload, and enhancing care access, ...
Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...
The multidisciplinary RA care pathway achieved higher remission rates and faster disease control than usual care, despite more severe baseline conditions. The pathway's interdisciplinary model ...
Expanding PrEP access through pharmacies could improve uptake, especially in high HIV caseload areas, due to their greater availability compared to PrEP-prescribing facilities. The study used geocoded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results